Hospital
El Camino Hospital
El Camino Hospital was paid $6.41M by Medicaid between Jan 2018 and Dec 2024, across 176 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 17% of everything it billed.
33Billing provider infoEL CAMINO HOSPITAL
MOUNTAIN VIEW, CA 94040
MOUNTAIN VIEW, CA 94040
33aNPI1093712374assigned 07/01/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.41M
24GClaims437,753
24DCodes billed176
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#211 of 410
Median peer was paid$6.90M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,079 | $557K | |
| 2019 | 47,650 | $545K | |
| 2020 | 40,315 | $583K | |
| 2021 | 61,478 | $837K | |
| 2022 | 66,848 | $1.17M | |
| 2023 | 86,176 | $1.36M | |
| 2024incomplete | 83,207 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 17% | 7,711 | 7,531 | $1.08M |
| 0450 | Emergency room services | 15% | 54,732 | 48,547 | $976K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 3,311 | 3,239 | $341K |
| 99199 | Unlisted special service, procedure or report | 4.6% | 5,877 | 5,056 | $294K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.7% | 1,663 | 1,558 | $238K |
| Z7502 | 3.6% | 6,362 | 5,917 | $231K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.5% | 19,282 | 17,681 | $223K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.4% | 4,429 | 4,288 | $215K |
| 80053 | Comprehensive metabolic panel | 2.9% | 35,683 | 31,406 | $183K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 5,153 | 4,677 | $140K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.1% | 2,133 | 2,108 | $135K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 37,254 | 32,384 | $133K |
164 more codes
| 36415 | Collection of venous blood by venipuncture | 1.7% | 2,657 | $107K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.6% | 4,097 | $103K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 4,258 | $99K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.4% | 1,507 | $89K |
| 99284 | Emergency room visit (serious) | 1.3% | 3,004 | $84K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 10,849 | $69K |
| 0510 | <1% | 2,841 | $61K | |
| 84484 | <1% | 14,433 | $61K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 980 | $60K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,240 | $58K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,402 | $56K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 55 | $51K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,849 | $49K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,938 | $47K |
| 99283 | Emergency room visit (moderate) | <1% | 1,305 | $45K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,670 | $42K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,353 | $41K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,988 | $41K |
| 83690 | <1% | 12,064 | $41K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,567 | $35K |
| 83880 | <1% | 3,592 | $35K | |
| 81001 | <1% | 20,971 | $35K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,032 | $35K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,221 | $31K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,630 | $31K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,139 | $31K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 397 | $31K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 900 | $30K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,228 | $29K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,519 | $27K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,774 | $27K |
| 87486 | <1% | 1,655 | $25K | |
| 87581 | <1% | 1,657 | $25K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,837 | $24K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,968 | $24K |
| J0897 | Injection, denosumab, 1 mg | <1% | 42 | $24K |
| G0378 | Hospital observation service, per hour | <1% | 341 | $23K |
| 93971 | <1% | 393 | $18K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,005 | $18K |
| 76830 | Ultrasound, transvaginal | <1% | 467 | $17K |
| 83735 | <1% | 6,141 | $16K | |
| 87040 | <1% | 3,185 | $16K | |
| 83605 | <1% | 3,605 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,445 | $15K |
| 0250 | <1% | 1,006 | $14K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 181 | $14K |
| 84439 | <1% | 3,495 | $13K | |
| 87631 | <1% | 530 | $12K | |
| 0270 | <1% | 2,145 | $12K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,529 | $12K |
| 85379 | <1% | 2,444 | $12K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 520 | $10K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 914 | $10K |
| 76801 | <1% | 317 | $10K | |
| 81025 | <1% | 2,915 | $9K | |
| 82077 | <1% | 1,649 | $9K | |
| 0762 | <1% | 184 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,767 | $9K |
| 80143 | <1% | 1,311 | $8K | |
| 80179 | <1% | 1,304 | $8K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,626 | $7K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,544 | $7K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,257 | $7K |
| 87081 | <1% | 2,813 | $7K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,440 | $6K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,924 | $6K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,854 | $6K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 187 | $6K |
| 82553 | <1% | 1,188 | $6K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 58 | $5K |
| 85730 | <1% | 2,683 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 635 | $5K |
| J3490 | Unclassified drugs | <1% | 572 | $5K |
| 85610 | <1% | 4,051 | $5K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 38 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,217 | $5K |
| 87186 | <1% | 2,118 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,629 | $5K |
| 86140 | <1% | 2,215 | $5K | |
| 70496 | <1% | 72 | $4K | |
| 86850 | <1% | 1,642 | $4K | |
| 82550 | <1% | 1,781 | $4K | |
| 73630 | <1% | 474 | $4K | |
| 73610 | <1% | 428 | $4K | |
| 99285 | Emergency room visit (most serious) | <1% | 93 | $4K |
| 73030 | <1% | 373 | $4K | |
| 0360 | <1% | 113 | $4K | |
| 87077 | <1% | 1,894 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 117 | $3K |
| 70498 | <1% | 84 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 634 | $3K |
| 90839 | <1% | 121 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,043 | $3K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,097 | $3K |
| 86901 | <1% | 1,779 | $2K | |
| 85027 | <1% | 974 | $2K | |
| 82803 | <1% | 311 | $2K | |
| 87807 | <1% | 661 | $2K | |
| 86900 | <1% | 1,778 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 214 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 899 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 39 | $2K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 751 | $2K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 130 | $1K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 376 | $1K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 411 | $1K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 25 | $1K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 714 | $1K |
| 82330 | <1% | 223 | $1K | |
| 84100 | <1% | 691 | $1K | |
| 96367 | <1% | 45 | $1K | |
| 80061 | Lipid panel | <1% | 490 | $1K |
| 71250 | <1% | 13 | $1K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 96 | $1K |
| 0710 | <1% | 240 | $979.25 | |
| 84145 | <1% | 231 | $945.32 | |
| 87147 | <1% | 552 | $928.82 | |
| 82728 | <1% | 280 | $892.27 | |
| 82378 | <1% | 217 | $887.07 | |
| 81003 | <1% | 409 | $820.30 | |
| 73562 | <1% | 139 | $767.39 | |
| 90715 | <1% | 63 | $682.23 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $499.63 |
| 71020 | <1% | 20 | $485.96 | |
| 83550 | <1% | 236 | $483.53 | |
| 72131 | <1% | 12 | $473.76 | |
| 85651 | <1% | 355 | $426.02 | |
| 83540 | <1% | 236 | $407.87 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 161 | $391.19 |
| 93308 | <1% | 15 | $387.54 | |
| 73564 | <1% | 37 | $380.91 | |
| 86308 | <1% | 181 | $373.24 | |
| 87210 | <1% | 96 | $370.88 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 419 | $350.33 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 28 | $339.76 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 234 | $326.42 |
| 85652 | <1% | 309 | $290.92 | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 26 | $270.20 |
| 71010 | <1% | 14 | $208.46 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 109 | $207.25 |
| 97161 | <1% | 40 | $207.23 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 113 | $176.28 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 85 | $175.00 |
| 72100 | <1% | 12 | $171.20 | |
| 88342 | <1% | 12 | $158.22 | |
| 73080 | <1% | 13 | $154.27 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 99 | $133.80 |
| 94760 | <1% | 28 | $131.05 | |
| A9270 | Non-covered item or service | <1% | 1,718 | $64.84 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 14 | $48.14 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 21 | $45.42 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 20 | $30.33 |
| 82270 | <1% | 26 | $28.56 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 40 | $25.63 |
| 82565 | <1% | 15 | $19.48 | |
| 82607 | <1% | 12 | $15.30 | |
| 84132 | <1% | 12 | $13.53 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 262 | $10.62 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 16 | $5.54 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 129 | $3.87 |
| 0272 | <1% | 24 | $3.66 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 572 | $0.02 |
| 0300 | 0% | 24 | $0.00 | |
| 96376 | 0% | 178 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWOO, MING-RONG (DIRECTOR OF REVENUE & REIMBURSEMENT)
| Provider | Location | Paid |
|---|---|---|
| El Camino Hospital | Los Gatos, CA | $857K |
| El Camino Hospital | Los Gatos, CA | $30K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.